Moreover, although ZHX2 has been identified as a tumor suppressor gene in HCC and can promote chemotherapy sensitivity in HCC, its role in regulating the l-125-induced anticancer effects remains unclear [23–25]. The gene discussed is ZHX2; the disease is neoplasm.